These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1199247)

  • 1. [Studies on the influence of body weight and form of therapy on the development of fatty liver in maturity-onset diabetes].
    Hanefeld M; Naumann HJ; Stötzner H; Haller H
    Z Gesamte Inn Med; 1975 May; 30(10):59-60. PubMed ID: 1199247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Statistical studies on the effect of diabetes type and its treatment on the extent and occurrence of fatty degeneration of the liver in diabetes mellitus].
    Hanefeld M; Naumann HJ; Haller H
    Dtsch Z Verdau Stoffwechselkr; 1967 Aug; 27(1):13-9. PubMed ID: 5595289
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the clinical use of biguanides].
    Haese E
    Arzneimittelforschung; 1969 Apr; 19(4):633-8. PubMed ID: 5819164
    [No Abstract]   [Full Text] [Related]  

  • 4. [Place of hypoglycemic sulfonamides in treatment of steatosis of nutritional origin].
    Dorf G; Tutin M; Bour H; Guy-Grand B
    Therapeutique; 1969 May; 45(5):536-7. PubMed ID: 5791835
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pathogenesis of non-alcoholic fatty liver and potential therapeutic targets].
    Crespo J; Cayón A; Pons-Romero F
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():15-23. PubMed ID: 15195530
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relationships between diabetes mellitus and fatty liver].
    Beringer A; Thaler H
    Dtsch Med Wochenschr; 1970 Apr; 95(15):836-8. PubMed ID: 5439535
    [No Abstract]   [Full Text] [Related]  

  • 7. [Metabolic diseases and fatty liver].
    Beringer A
    Z Gesamte Inn Med; 1977 May; 32(10):150-2. PubMed ID: 906584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [On the cause and treatment of the senile diabetes].
    Beringer von A; Geyer G; Mösslacher H; Tragl KH; Waldhäusl W
    Wien Klin Wochenschr; 1968 Mar; 80(12):219-29. PubMed ID: 5728262
    [No Abstract]   [Full Text] [Related]  

  • 9. Nationwide survey to compare the prevalence of transient elevation of liver transaminase during treatment of diabetic ketosis or ketoacidosis in new-onset acute and fulminant type 1 diabetes mellitus.
    Takaike H; Uchigata Y; Iwamoto Y; Imagawa A; Iwahashi H; Kanatsuka A; Kawasaki E; Kobayashi T; Shimada A; Shimizu I; Maruyama T; Hanafusa T; Makino H
    Ann Med; 2008; 40(5):395-400. PubMed ID: 18484350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diabetes and tuberculosis. Current status].
    Palenzona C; Pucci G; Valentino V
    Minerva Med; 1975 Jan; 66(3):135-7. PubMed ID: 1118077
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of routine serochemical methods for the study of liver involvement in diabetes mellitus].
    Heller H
    Z Gesamte Inn Med; 1971 May; 26(10):Suppl:120-4. PubMed ID: 5131405
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination of drugs in the management of diabetes mellitus.
    Das S
    J Indian Med Assoc; 2002 Jul; 100(7):434, 436, 445-7. PubMed ID: 12674168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Morhpological and clinical findings in the liver in diabetes mellitus].
    Takác A; Langsch HG; Cossel L
    Dtsch Z Verdau Stoffwechselkr; 1967 Feb; 26(4):188-97. PubMed ID: 5595286
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hypertriglyceridemia and diabetes].
    Canaani Z; Regev R
    Harefuah; 1980 Mar; 98(5):201-3. PubMed ID: 6997145
    [No Abstract]   [Full Text] [Related]  

  • 15. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results.
    Meinert CL; Knatterud GL; Prout TE; Klimt CR
    Diabetes; 1970; 19():Suppl:789-830. PubMed ID: 4926376
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intensified therapy of newly detected maturity onset diabetes].
    Pissarek D; Panzram G; Lundershausen R; Adolph W; Senf L
    Endokrinologie; 1980 Jan; 75(1):105-15. PubMed ID: 6989592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quantitative relations between sero-chemical findings, fatty degeneration of the liver, alcohol drinking and body weight in a diabetic and non-diabetic collective with fatty degeneration of the liver].
    Fuchs T; Immich H; Nedden R
    Med Welt; 1971 Mar; 10():392-9. PubMed ID: 5549139
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance.
    Roden M
    Nat Clin Pract Endocrinol Metab; 2006 Jun; 2(6):335-48. PubMed ID: 16932311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remarks concerning some recent reports on therapy of diabetes.
    Laubatières A
    Isr J Med Sci; 1972 Jun; 8(6):883-7. PubMed ID: 4559429
    [No Abstract]   [Full Text] [Related]  

  • 20. [Late failures of oral therapy of diabetes].
    Kaeding A; Werner P
    Dtsch Z Verdau Stoffwechselkr; 1965 Nov; 25(5):305-12. PubMed ID: 5888991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.